Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS
1 other identifier
interventional
200
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the effect of an Enhanced Recovery After Surgery(ERAS) protocol in patients undergoing gynecologic laparoscopic surgery under general anesthesia. The main question it aims to answer is: Does the ERAS protocol improve the quality of recovery compared to standard treatments? Researchers will compare ERAS protocol with standard treatment to see if ERAS protocol improves the quality of recovery after surgery. Participants will:
- Receive ERAS protocol during the hospitalization
- Undergo bio-signal monitoring for one month using Hi-Cardi Plus device and Galaxy Watch 7
- Visit the hospital at one week and one month after discharge
- Complete questionnaires(QOR-15K, WHO-DAS 2.0, EQ-5D-3L) at 24 hours after surgery, at discharge, one week after discharge, and one month after discharge
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2025
CompletedFirst Posted
Study publicly available on registry
August 28, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
ExpectedAugust 28, 2025
August 1, 2025
1 month
July 31, 2025
August 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Quality of Recovey-15, Korean version (QoR-15K)
This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.
on 24 hours postoperatively
Quality of Recovey-15, Korean version (QoR-15K)
This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.
one week after hospital discharge
Quality of Recovey-15, Korean version (QoR-15K)
This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.
one month after hospital discharge
The World Health Organization Disability Assessment Schedule, 2nd Edition (WHODAS 2.0)
WHODAS 2.0 questionnaire consists of 36 items rated on a 5-point Likert scale (1-5), yielding a total score ranging from 36 to 180. Higher scores represent greater disability and poorer functioning.
on 24 hours postoperatively
The World Health Organization Disability Assessment Schedule, 2nd Edition (WHODAS 2.0)
WHODAS 2.0 questionnaire consists of 36 items rated on a 5-point Likert scale (1-5), yielding a total score ranging from 36 to 180. Higher scores represent greater disability and poorer functioning.
one week after hospital discharge
The World Health Organization Disability Assessment Schedule, 2nd Edition (WHODAS 2.0)
WHODAS 2.0 questionnaire consists of 36 items rated on a 5-point Likert scale (1-5), yielding a total score ranging from 36 to 180. Higher scores represent greater disability and poorer functioning.
one month after hospital discharge
EuroQol 5-Dimension, 3-Level questionnaire (EQ-5D-3L)
EQ-5D-3L questionnaire assesses health-related quality of life across five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each domain is rated on a 3-level scale (1 = no problems, 2 = some problems, 3 = extreme problems), where higher scores within each domain indicate worse health status.
on 24 hours postoperatively
EuroQol 5-Dimension, 3-Level questionnaire (EQ-5D-3L)
EQ-5D-3L questionnaire assesses health-related quality of life across five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each domain is rated on a 3-level scale (1 = no problems, 2 = some problems, 3 = extreme problems), where higher scores within each domain indicate worse health status.
1 week after hospital discharge
EuroQol 5-Dimension, 3-Level questionnaire (EQ-5D-3L)
EQ-5D-3L questionnaire assesses health-related quality of life across five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each domain is rated on a 3-level scale (1 = no problems, 2 = some problems, 3 = extreme problems), where higher scores within each domain indicate worse health status.
1 month after hospital discharge
Secondary Outcomes (7)
Pain (Visual analogue scale)
on 24 hours postoperatively
Pain (Visual analogue scale)
1 week after hospital discharge
Pain (Visual analogue scale)
1 month after hospital discharge
Length of stay
throughout hospitalization, expected to be 2-3 days
Total in-hospital opioid consumption
throughout hospitalization, expected to be 2-3 days
- +2 more secondary outcomes
Other Outcomes (1)
Heart rate variability
From discharge day to one month after discharge
Study Arms (2)
ERAS
EXPERIMENTALConventional
ACTIVE COMPARATORInterventions
1. Before surgery * Sips of water until 6 AM on the day of surgery, followed by a 200 mL carbohydrate drink * Pre-emptive oral analgesics (celecoxib 200mg 1 cap + acetaminophen 650mg 2 tab) 2. During surgery * Total intravenous anesthesia * Local anesthetic infiltration at the laparoscopic port site for post-operative pain control 3. After surgery * Sips of water and a foley catheter removal on ward arrival * Soft meal 4 housr after surgery * General diet 8 hours after surgery
1. Before surgery * Midnight NPO * No pre-emptive analgesics 2. During surgery * Balanced anesthesia 3. After surgery * Sips of water 8 hours after arrival in the ward * Foley catheter removal one day after the surgery * Soft meal after gas out * General diet after one soft meal
Eligibility Criteria
You may qualify if:
- Age between 20 and 70 years
- Scheduled to undergo gynecologic laparoscopic surgery under general anesthesia
- Use of an Android smartphone
You may not qualify if:
- American Society of Anesthesiologists(ASA) physical status classification IV or higher
- Body Mass Index (BMI) 35 or higher
- Presence of diabetic autonomic neuropathy
- History of esophageal hiatal hernia or delayed stomach discharge
- Known allergy to local anesthesia
- Participantion in other trials that may affect study outcomes
- Inability to complete questionnaires (e.g., due to cognitive impairment)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wonju Severance Christian Hospital
Wŏnju, Gangwon-do, 26426, South Korea
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
July 31, 2025
First Posted
August 28, 2025
Study Start
September 1, 2025
Primary Completion
October 1, 2025
Study Completion (Estimated)
October 1, 2026
Last Updated
August 28, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share